6.
Lijfering W, Sprenger H, Georg R, van der Meulen P, van der Meer J
. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem. 2008; 54(7):1226-33.
DOI: 10.1373/clinchem.2008.103614.
View
7.
Borjas-Howard J, Bierman W, Meijer K, van der Werf T, Tichelaar Y
. Venous thrombotic events in patients admitted to a tuberculosis centre. QJM. 2016; 110(4):215-218.
DOI: 10.1093/qjmed/hcw152.
View
8.
Jong E, Louw S, van Gorp E, Meijers J, Ten Cate H, Jacobson B
. The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost. 2010; 104(6):1228-34.
DOI: 10.1160/TH10-04-0233.
View
9.
Zimba S, Nutakki A, Chishimba L, Chomba M, Bahouth M, Gottesman R
. Risk factors and outcomes of HIV-associated stroke in Zambia. AIDS. 2021; 35(13):2149-2155.
DOI: 10.1097/QAD.0000000000002999.
View
10.
Erbe M, Rickerts V, Bauersachs R, Lindhoff-Last E
. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost. 2003; 9(4):325-31.
DOI: 10.1177/107602960300900408.
View
11.
Stellbrink H, Arribas J, Stephens J, Albrecht H, Sax P, Maggiolo F
. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3,.... Lancet HIV. 2019; 6(6):e364-e372.
DOI: 10.1016/S2352-3018(19)30080-3.
View
12.
Saif M, Bona R, Greenberg B
. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS. 2001; 15(6):311-20.
DOI: 10.1089/108729101750279687.
View
13.
Jacobson M, Dezube B, Aboulafia D
. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis. 2004; 39(8):1214-22.
DOI: 10.1086/424664.
View
14.
Copur A, Smith P, Gomez V, Bergman M, Homel P
. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS. 2002; 16(5):205-9.
DOI: 10.1089/10872910252972258.
View
15.
Borjas Howard J, Rokx C, Smit C, Wit F, Pieterman E, Meijer K
. Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study. Lancet HIV. 2019; 6(3):e173-e181.
DOI: 10.1016/S2352-3018(18)30333-3.
View
16.
Rasmussen L, Dybdal M, Gerstoft J, Kronborg G, Larsen C, Pedersen C
. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med. 2010; 12(4):202-10.
DOI: 10.1111/j.1468-1293.2010.00869.x.
View
17.
Olson J, Schwab P, Jackson J, Lange J, Bedair H, Abdeen A
. HIV-Positive Patients Are at Increased Risk of Venous Thromboembolism After Total Joint Replacement. J Am Acad Orthop Surg. 2020; 29(11):479-485.
DOI: 10.5435/JAAOS-D-20-00737.
View
18.
Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R, Montiel-Manzano G, Trevino-Perez S, Santoscoy-Gomez M
. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost. 2004; 10(1):19-25.
DOI: 10.1177/107602960401000104.
View
19.
Jackson B, Pretorius E
. Pathological Clotting and Deep Vein Thrombosis in Patients with HIV. Semin Thromb Hemost. 2018; 45(2):132-140.
DOI: 10.1055/s-0038-1676374.
View
20.
Arab K, Spence A, Czuzoj-Shulman N, Abenhaim H
. Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet. 2017; 295(3):599-606.
DOI: 10.1007/s00404-016-4271-y.
View